Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  p53/HDM2 interaction inhibitor CGM097
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CCGM097X2101, NCI-2014-00204, 2012-000940-87, NCT01760525
Start Over